ScreenCell technology is a versatile liquid biopsy technology designed to capture Circulating Tumor Cells (CTCs) non-invasively from a simple blood sample in patients with solid cancers.
ScreenCell technology has been developed into 7 single-use kits dedicated to the isolation of circulating tumor cells. Each kit is designed for distinct and specific applications.
Discover our two filtration devices: CYTO and MB.
They are both equipped with a specific isolation support, thus offering a multitude of applications in cytology, molecular biology and cell culture.
CYTO
filtration unit
CYTO
isolation support
MB
filtration unit
MB
isolation support
ScreenCell technology stands out from other methods due to its remarkable ease of use.
In fact, our circulating tumor cells test offer its users the possibility of efficiently and quickly capturing CTCs, thanks to the absence of any machine constraints in just 3 simple steps: dilution, filtration and ejection.
For more than 10 years, ScreenCell has chosen to develop its expertise in collaboration with local suppliers and partners in order to promote excellence and French and European national know-how.
We are committed to providing our customers with quality products and we believe this requires controlled production, from design to manufacturing.
We carefully select the raw materials used in our circulating tumor cells test and we work in close collaboration with French and European companies to guarantee an impeccable level of finish.
Use our test to find out which ScreenCell kit is right for you.
Find the perfect solution in just a few clicks.
ScreenCell technology is specifically designed for use on solid cancers, such as breast, lung, prostate, colon and many others.
This technology is not suitable for hematological cancers, such as leukemia or lymphoma, which affect the blood or lymphatic organs without forming solid tumors.
Our circulating tumor cells test is designed to be used stand-alone without the need for any specific additional equipment.
However, for some more advanced analyses, you may need additional equipment such as digital PCR or FACS for more detailed examinations or additional tests.
By Amira Mehtar, Janine Wechsler, Christophe Desterke, Julien Giron-Michel, Amira Bouzidi, Aude Burlion, Fawzia Louache, Samira Kahia-Tani , Georges Uzan, and Sina Naserian
